Proteome profiling for the identification of lung cancer signatures

    loading  Checking for direct PDF access through Ovid

Abstract

Evaluation of: Taguchi A, Politi K, Pitteri SJ et al. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 20(3), 289–299 (2011).

Comprehensive and in-depth discovery of the disease proteome is an important issue in recent proteomics developments. Previous studies have shown a number of biomarkers discovered in various diseases, including lung cancer. Some of them are potentially useful in lung cancer diagnostics and prognostics. However, few of them can act as organ-specific biomarkers to extensively compare multiple cancer models. This article evaluates a recently published study employing comparative proteomics on multiple genetically engineered mouse models and sheds light on the usefulness and application of the discovered marker panel for human lung cancer diagnostics.

Related Topics

    loading  Loading Related Articles